Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04073823 · ClinicalTrials.gov registry record · NA
A Study Evaluating FT-SW in Unilateral Breast Cancer-Related Lymphedema Patients
A NA study, sponsored by Tactile Medical.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT04073823 is a NA study that was terminated before completion, run by Tactile Medical. The registered enrollment target is 2 participants.
The verdict
NCT04073823, a NA study, was terminated before completion, sponsored by Tactile Medical.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The objective of the study is to demonstrate equivalency in treatment effect, as determined by objective measurements, between the modified therapy cycle software and the FDA-cleared Flexitouch therapy cycle software.
Interventions
- DEVICE Flexitouch Plus
- DEVICE Flexitouch Plus FT with software modification
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2020-01-23 |
| Est. Completion | 2020-02-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04073823
The ClinicalTrials.gov registry entry for NCT04073823 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tactile Medical, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Flexitouch Plus is the first listed.
NCT04073823 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04073823 about?
NCT04073823 is a clinical study titled "A Study Evaluating FT-SW in Unilateral Breast Cancer-Related Lymphedema Patients". The objective of the study is to demonstrate equivalency in treatment effect, as determined by objective measurements, between the modified therapy cycle software and the FDA-cleared Flexitouch therapy cycle software.
What is the current status of trial NCT04073823?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2020-01-23. Estimated completion is 2020-02-08.
What interventions are being tested in trial NCT04073823?
The interventions under investigation include: Flexitouch Plus (DEVICE), Flexitouch Plus FT with software modification (DEVICE).
Who is sponsoring clinical trial NCT04073823?
This trial is sponsored by Tactile Medical, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.